A practical reference on counter-ion: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-01-02. Anything still debated is marked as such rather than presented as settled.
The lyophilized peptide is a white to off-white powder that dissolves freely in water and in aqueous buffers near neutral pH. Because the molecule carries a net negative charge under physiological conditions, saline and phosphate solutions are the usual vehicles, while strongly acidic media are avoided. Stock solutions are commonly divided into small aliquots so that repeated freezing and thawing can be limited, since cycling may encourage aggregation. Solubility in organic solvents is poor and those solvents are seldom used as primary diluents.
Recommended storage for the dry powder is a freezer near minus twenty degrees Celsius, kept desiccated and away from light. Once dissolved, the peptide is less stable and is usually held at two to eight degrees Celsius for short intervals or frozen for longer storage. Stability studies focus on the acetylated terminus and the disulfide linkage because those features define the intact molecule. Common degradation routes include cysteine oxidation, deamidation of asparagine or glutamine side chains, and slow formation of higher-molecular-weight species.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Assessed by visual inspection at release |
| Solubility class | Freely soluble in water | Aqueous buffers near neutral pH |
| Typical storage temperature | Minus 20 degrees Celsius | Lyophilized, desiccated, protected from light |
| Typical analytical method | Reverse-phase HPLC with mass spectrometry | Used together for purity and identity |
| Common synonyms | T-alpha-1; thymalfasin | Older reports use several designations |
Identity and purity are normally assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and truncation products. Mass spectrometry confirms molecular mass and detects modifications such as deamidation or oxidation. Amino acid analysis and peptide mapping provide additional sequence-level confirmation. For research material, a certificate of analysis typically reports these results together with water content and counter-ion identity, since the lyophilized powder is often supplied as an acetate or trifluoroacetate salt.
Several factors accelerate degradation: alkaline pH, elevated temperature, exposure to oxidants, and the presence of residual moisture. Deamidation of asparagine residues and oxidation of methionine are the most commonly reported degradation routes. Because the peptide lacks disulfide bonds, it does not undergo the thiol-related aggregation seen in some other biologics, but physical aggregation can still occur at high concentration. Stability data are product-specific, and extrapolating shelf life between formulations is not reliable.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide lacks cysteine, methionine, and tryptophan, so disulfide scrambling and sulfur oxidation are not major degradation routes. Instead, aspartate residues can undergo isomerization or cyclization to succinimide intermediates, generating isoaspartate variants. Hydrolysis of peptide bonds also occurs slowly in solution. These changes may reduce biological activity even when the main peak remains detectable. Stability studies therefore track both potency and the appearance of related substances.
Lyophilized thymosin alpha 1 is typically stored refrigerated at 2 to 8 degrees Celsius and kept away from light. Reconstituted solutions are less stable and are usually used promptly after preparation. Repeated freeze-thaw cycles are avoided because they can promote aggregation and loss of activity. The peptide adsorbs to some plastic and glass surfaces, so a carrier protein is often added to dilute working solutions. Manufacturer instructions and published protocols both govern handling.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Consultant Urologist, South Tyneside and Sunderland NHS Foundation Trust. For services to the NHS. Dr. Benjamin Marc Ellis. For services to Healthcare, to Equality and to the Jewish Community. Audley Horace English. Co-Founder, Society of Black Architects. For services to Architecture and Sustainability. Professor Stephen James Weston Evans. Emeritus Professor of Pharmacoepidemiology, London School of Hygiene and Tropical Medicine. For services to the Safety of Medicines. Stephen Wynne Evans. Founder, Belief. For voluntary and charitable services in North Wales. Helen Adesuwa Imatitkua Fadipe. Founder and Chair, BAME Planners Network. For services to Town Planning. Paul Fairweather. Trustee, Breakthrough Ltd. For services to Disabled People and to the LGBT Community in the North West. Catherine Susan, Baroness Fall. Lately Non Executive Director, Cultural Recovery Board. For services to Culture. Rhiane Estelle Fatinikun. Founder, Black Girls Hike. For services to Nature and to Diversity. Julie Patricia Felix. For services to Dance Education. James St John Fenny. Head of Office, Public Defender Service and Transplant Surgery Ambassador. For services to Criminal Justice and to Organ Donor Awareness. Dr. Julia Helen Fentem. Executive Vice President, Safety, Environmental and Regulatory Science, Unilever. For services to Human Health and Animal Welfare. Jacqueline Ferguson. President, London College of Dance Network and Volunteer, Healthwatch (Kensington and Chelsea). For services to the community in London. Lucy Catherine Ferguson. Founder and Director, Mediorite.
=== Structural Biology and Protein Engineering === This program studies biomolecules using protein engineering and molecular biology techniques. Methodologies include X-ray crystallography and cryo-EM. Research includes protein structure determination and mass spectrometry methods.
McCoy warned that, if China's numerous breaches on Taiwan become "a crippling embargo of Taiwan", the US would lose Taiwan, risking a break of "America's island chain in the Pacific littoral, pushing it back to a 'second island chain' in the mid-Pacific", regardless of the US's decisions on Taiwan. He further cited growing anti-American sentiment in the Philippines, the opposition toward AUKUS (trilateral security partnership between Australia, the United Kingdom, and the United States) from certain members of the Labor Party as a threat to Australia's sovereignty, and the Republican Party populism in the US under Trump (or his successor-in-line JD Vance) potentially curtailing the US's ability to maintain its alliance with the Asia-Pacific countries. In January 2025, almost two weeks before Biden ended his term, Hoover Institution senior fellow Niall Ferguson wrote that the US has had "a second cold war" with China for at least six years and that the war further intensified under the Biden administration. Ferguson drew comparisons between Trump and then-US president Ronald Reagan, like assassination attempts on them, but further suggested that Trump use the Reagan administration's past approach in foreign policy.
Sources: en.wikipedia.org
Pyteomics also functions as a versatile and lightweight toolkit, but supports a broader range of common proteomics formats (including mgf and pepxml) and is often utilized for its use in general data handling and calculations. For more specific applications, matchms is dedicated to data processing, cleaning, and comparison, particularly for implementing various spectral similarity scoring algorithms in metabolomics.
== Awards and honors == Sheiner received the Oscar B. Hunter Award, the highest honor of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), in 2004. He was given an Honorary Doctorate from Uppsala University, Sweden in 1995 and received the Rawls Palmer Progress in Medicine Award of the ASCPT in 1989. Posthumously, several awards have been named in Sheiner's honor, including the International Society of Pharmacometrics (ISoP) Lewis B. Sheiner Lecturer Award and the ASCPT's Sheiner-Beal Pharmacometrics Award.
=== December === December 1 – COVID-19 pandemic: In California, the first case of Omicron variant, a highly mutated variant of COVID-19, is reported by the CDC in a San Francisco resident, who had traveled to South Africa. December 2 Major League Baseball begins a lockout of its players. It is their first lockout since 1990. COVID-19 pandemic: Minnesota reports their first case of Omicron variant. Two Georgia election officials, Ruby Freeman and Wandrea' ArShaye Moss, file a defamation lawsuit against The Gateway Pundit. The lawsuit is the first to be filed by individual election workers who were targeted during the 2020 presidential election. December 4 – Chris Cuomo is fired by CNN for his violations of journalistic ethics by aiding his scandal-ridden brother. December 9 Workers at a Starbucks in Buffalo, New York vote 19–8 to unionize, becoming the first Starbucks in the country to do so. A virtual summit, Summit for Democracy, was hosted by the United States "to renew democracy at home and confront autocracies abroad". December 10 – A late season tornado outbreak occurs in the Southern and Midwestern United States, causing major damage and killing at least 94 people. December 11 COVID-19 pandemic: North Carolina reports its first case of the Omicron variant in a student at UNC Charlotte. The MLS Cup 2021 hosted in Portland, Oregon, New York City FC defeated Portland Timbers after won 4–2 on penalties (Both teams drew 1–1 in regulation and extra time).
Oxidative phosphorylation or electron transport-linked phosphorylation or terminal oxidation, is the metabolic pathway in which cells use enzymes to oxidize nutrients, thereby releasing chemical energy in order to produce adenosine triphosphate (ATP). In eukaryotes, this takes place inside mitochondria. Almost all aerobic organisms carry out oxidative phosphorylation. This pathway is so pervasive because it releases more energy than fermentation. In aerobic respiration, the energy stored in the chemical bonds of glucose is released by the cell in glycolysis and subsequently the citric acid cycle, producing carbon dioxide and the energetic electron donors NADH and FADH₂. Oxidative phosphorylation uses these molecules and O2 to produce ATP, which is used throughout the cell whenever energy is needed. During oxidative phosphorylation, electrons are transferred from the electron donors to a series of electron acceptors in a series of redox reactions ending in oxygen, whose reaction releases half of the total energy. In eukaryotes, these redox reactions are catalyzed by a series of protein complexes within the inner mitochondrial membrane; whereas, in prokaryotes, these proteins are located in the cell's plasma membrane. These linked sets of proteins are called the electron transport chain. In mitochondria, five main protein complexes are involved, whereas prokaryotes have various other enzymes, using a variety of electron donors and acceptors.
Sources: en.wikipedia.org
Reconstituted solutions are typically kept refrigerated at two to eight degrees Celsius when used within a short window, or frozen in aliquots for longer periods. Repeated freeze-thaw cycles are avoided because they can reduce recovery of intact peptide.
It establishes that the measured mass matches the expected value for the intact molecule. It also helps detect modifications such as oxidation or truncation that shift the mass by a known amount.
Cycling between frozen and liquid states can promote aggregation and adsorption to container walls. Dividing a stock into single-use aliquots limits the number of cycles a given vial undergoes.
Its sequence corresponds to the amino-terminal portion of prothymosin alpha, a larger protein present in many cell types. The isolated 28-residue peptide is a fragment of that protein rather than a separately encoded molecule, and laboratory material is produced by synthesis.